Revolution Medicines, Inc. (RVMDW) bonds
RVMDWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMD
$9.81+0.18 (+1.82%)
Close on Oct 30, 2026Market cap $41.00BP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Revolution Medicines reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Revolution Medicines's 10-Q for the period ended Jun 30, 2026
| Issue | Coupon | Matures | Amount issued | Carrying value |
|---|---|---|---|---|
| 0.50% Convertible Senior Notes Due 2033 Convertible at $199 a share | 0.50% | May 1, 2033 | $500.00M | $517.50M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.